T Cell News and Research

Latest T Cell News and Research

Cell signaling pathway may offer new drugs for tuberous sclerosis complex

Tuberous sclerosis complex (TSC) is a neurological disorder causing non-cancerous tumors, called cortical tubers, to grow throughout the brain and body, as well as other conditions like epilepsy and autism.

24 Jun 2020

Researchers develop a noninvasive technology to destroy cancer cells

An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at Tel Aviv University developed a noninvasive technology platform for gene delivery into breast cancer cells.

24 Jun 2020

Far-UVC light can efficiently and safely kill airborne coronaviruses

More than 99.9% of seasonal coronaviruses present in airborne droplets were killed when exposed to a particular wavelength of ultraviolet light that is safe to use around humans, a new study at Columbia University Irving Medical Center has found.

24 Jun 2020

'Very low' risk of adverse health effects related to RF exposure from 5G systems

Experts weigh in on recent online reports that warn of frightening health consequences from new fifth generation (5G) wireless networks.

24 Jun 2020

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

The use of cholesterol-lowering drugs called statins is associated with a lower death rate and a lower incidence of mechanical ventilation in patients hospitalized with Coronavirus disease 2019 (COVID-19), researchers report June 24 in Cell Metabolism.

24 Jun 2020

Tomocube holotomography microscopy reveals novel cholesterol membrane transport system in erythrocytes infected with fatal malaria parasite

The first study to elucidate the dynamics of membrane cholesterol transport in erythrocytes has been successfully concluded using holotomography microscopy.

From Tomocube Inc. 24 Jun 2020

Researchers investigate nelarabine drug for treating leukemia

Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine.

24 Jun 2020

New technique helps measure dNTP concentrations with greater sensitivity

A highly sensitive and easy-to-use technique applicable for tissue samples can be useful, for example, to researchers specialised in mitochondrial diseases and cancer.

24 Jun 2020

Researchers develop less invasive genetic tools to understand cellular activity

Graduate student Ubadah Sabbagh placed a cold glass slide on the microscope. It was getting late and the lab was quiet.

24 Jun 2020

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment.

From Kerafast 24 Jun 2020

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.

24 Jun 2020

Evidence of link between ACE2 genotype and COVID-19 disease severity

A new study published on the preprint server medRxiv in June 2020 shows that variants in the ACE2 gene which encodes the enzyme receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease, are linked to the risk of severe disease.

24 Jun 2020

Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion

A new study by researchers at Strasbourg University Hospital and published on the preprint server medRxiv* in June 2020 shows that COVID-19 antibody responses may sometimes be lacking following exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could lead to a significant underestimation of the number of infections and the number of individuals who have achieved immunity.

24 Jun 2020

U.K. to roll out the largest genetic study on chronic fatigue syndrome

Fatigue is the feeling of constant tiredness or weakness, which can affect anyone. In worse cases, people develop a condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This condition is debilitating and lacks a universally accepted definition, cause, diagnosis, and even treatment.

24 Jun 2020

Researchers report a key breakthrough to help protect newborns from brain damage

Oxygen deprivation can be the worst start to a newborn's life, resulting in brain damage, epilepsy, developmental delays and death.

23 Jun 2020

A new approach to track down cryptic peptides

Almost all cells of the human body present fragments of cellular proteins on their surface, so-called human leukocyte antigens or HLA peptides, which play an important role in the immune response.

23 Jun 2020

Discovery provides a potential target for infectious diseases immunotherapy

NIH investigators and colleagues have discovered that when the immune system first responds to infectious agents such as viruses or bacteria, a natural brake on the response prevents overactivation.

23 Jun 2020

Scientists create hollow, spherical sacks using protein and RNA

Using protein and RNA, scientists have created hollow, spherical sacks known as vesicles.

23 Jun 2020

Male COVID-19 patients produce more SARS-CoV-2 antibodies than women

Health officials in the United Kingdom urge male coronavirus survivors to donate blood, particularly its convalescent plasma component. This comes after a new study has found that men produce more antibodies, which could make their plasma a valuable treatment against the coronavirus disease (COVID-19).

23 Jun 2020

Smoking increases risk of COVID-19 for men but not women

Even as the COVID-19 pandemic continues to spread over the world, scientists have had to come to terms with the fact that they don’t know much about the SARS-CoV-2 or the disease it causes. Now, a new study by researchers at the University College Cork, Ireland, and published on the preprint server medRxiv in June 2020 discusses the differences in COVID-19 risk between men and women who smoke.

23 Jun 2020

T Cell News and Research

Latest T Cell News and Research

Cell signaling pathway may offer new drugs for tuberous sclerosis complex

Researchers develop a noninvasive technology to destroy cancer cells

Far-UVC light can efficiently and safely kill airborne coronaviruses

'Very low' risk of adverse health effects related to RF exposure from 5G systems

Statin therapy linked to lower death rate in hospitalized patients with COVID-19

Tomocube holotomography microscopy reveals novel cholesterol membrane transport system in erythrocytes infected with fatal malaria parasite

Researchers investigate nelarabine drug for treating leukemia

New technique helps measure dNTP concentrations with greater sensitivity

Researchers develop less invasive genetic tools to understand cellular activity

Kerafast offers the Delta-G-VSV Pseudotyping System for coronavirus research

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

Evidence of link between ACE2 genotype and COVID-19 disease severity

Exposure to SARS-CoV-2 can induce virus-specific T cell responses without seroconversion

U.K. to roll out the largest genetic study on chronic fatigue syndrome

Researchers report a key breakthrough to help protect newborns from brain damage

A new approach to track down cryptic peptides

Discovery provides a potential target for infectious diseases immunotherapy

Scientists create hollow, spherical sacks using protein and RNA

Male COVID-19 patients produce more SARS-CoV-2 antibodies than women

Smoking increases risk of COVID-19 for men but not women

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in